Adverse Events Monitoring, Pharmacovigilance, Risk Management, and Recalls Adverse Events Monitoring, Pharmacovigilance and Risk Management - March 2015 by Katharine R. Latimer, Partner at Hollingsworth LLP (Washington, DC), Linda Pissott Reig, Shareholder at Buchanan Ingersoll & Rooney PC